Apple Reports Results… And Novo Nordisk’s Obesity Drug Price Cut 5/2/24
CNBC's "Fast Money"
00:00
Introduction
This chapter delves into Apple's record-breaking buyback announcement, Peloton's challenges leading to a stock drop and executive changes, and Novo Nordisk's resilient sales performance in a competitive landscape.
Play episode from 00:00
Transcript
